Event Group
Event Groups are part of the Adverse Events Module within the Results Section. They provide a way to organize and summarize adverse event data by grouping related events together.
Each Event Group typically represents a category or class of adverse events and includes statistical information such as the number of participants affected and at risk for different event types: deaths, serious events, and other events.
Event Group path is as follows:
Study -> Results Section -> Adverse Events Module -> Event Group
Event Group
Ignite Creation Date:
2025-12-24 @ 5:58 PM
Ignite Modification Date:
2025-12-25 @ 3:21 PM
NCT ID:
NCT04853368
Group ID:
EG001
Title:
Cohort 1(Day 1 - 29) Triple Combination Galicaftor + Navocaftor + ABBV-119 for F508del Homozygous
Description:
F508del homozygous CF participants from Cohort 1(Day -29 to -1) who received Galicaftor/ Navocaftor dual combination therapy.
followed by
Galicaftor/Navocaftor/ABBV-119 triple combination therapy (Day 1- 29).
Galicaftor: 300 mg QD, Oral capsules
Navocaftor: 50 mg QD, Oral capsules
ABBV-119: 210 mg BID, Oral capsules
Deaths Number Affected:
0
Deaths Number At Risk:
None
Serious Number Affected:
1
Serious Number At Risk:
24
Other Number Affected:
10
Other Number At Risk:
24
Study:
NCT04853368
Results Section:
NCT04853368
Adverse Events Module:
NCT04853368